SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-137639
Filing Date
2020-05-08
Accepted
2020-05-08 16:39:39
Documents
16
Period of Report
2020-05-07
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d926828d8k.htm   iXBRL 8-K 59378
2 EX-99.1 d926828dex991.htm EX-99.1 91945
3 EX-99.2 d926828dex992.htm EX-99.2 22423
7 GRAPHIC g926828dsp8.jpg GRAPHIC 1979
8 GRAPHIC g926828g0508084245887.jpg GRAPHIC 2692
  Complete submission text file 0001193125-20-137639.txt   317785

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA zyme-20200507.xsd EX-101.SCH 2729
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE zyme-20200507_lab.xml EX-101.LAB 18083
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zyme-20200507_pre.xml EX-101.PRE 11369
15 EXTRACTED XBRL INSTANCE DOCUMENT d926828d8k_htm.xml XML 3340
Mailing Address 540-1385 WEST 8TH AVENUE Vancouver A1 V6H 3V9
Business Address 540-1385 WEST 8TH AVENUE Vancouver A1 V6H 3V9 (604) 678-1388
Zymeworks Inc. (Filer) CIK: 0001403752 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38068 | Film No.: 20861207
SIC: 2834 Pharmaceutical Preparations